Affinity DataKi: 1.70nMAssay Description:Competitive inhibition of human recombinant DAAO by Michaelis-Menten plot analysis in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataKi: 3.5nMAssay Description:Competitive inhibition of human recombinant DAAO by Michaelis-Menten plot analysis in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataKi: 7.20nMAssay Description:Competitive inhibition of human recombinant DAAO by Michaelis-Menten plot analysis in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Competitive inhibition of human recombinant DAAO by Michaelis-Menten plot analysis in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataKi: 190nMAssay Description:Competitive inhibition of human recombinant DAAO by Michaelis-Menten plot analysis in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataKi: 2.00E+3nMAssay Description:Competitive inhibition of human recombinant DAAO by Michaelis-Menten plot analysis in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataKi: 3.40E+3nMAssay Description:Competitive inhibition of pig kidney DAAO in presence of D-alanineMore data for this Ligand-Target Pair
Affinity DataIC50: 3.10nMAssay Description:Competitive inhibition of human recombinant DAAO after 1 hr by coupled enzyme assay in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataIC50: 5.40nMAssay Description:Inhibition of DAAO (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 5.40nMAssay Description:Competitive inhibition of human recombinant DAAO after 1 hr by coupled enzyme assay in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Competitive inhibition of human recombinant DAAO after 1 hr by coupled enzyme assay in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:Competitive inhibition of human recombinant DAAO after 1 hr by coupled enzyme assay in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataIC50: 219nMAssay Description:Competitive inhibition of human recombinant DAAO after 1 hr by coupled enzyme assay in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataIC50: 2.09E+3nMAssay Description:Competitive inhibition of human recombinant DAAO after 1 hr by coupled enzyme assay in presence of D-serineMore data for this Ligand-Target Pair
Affinity DataKd: 2.50E+3nMAssay Description:Binding affinity to human recombinant DAAO at 520 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 4.80E+3nMAssay Description:Binding affinity to human recombinant DAAO at 440 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 3.20E+3nMAssay Description:Binding affinity to human recombinant DAAO at 600 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 3.60E+3nMAssay Description:Binding affinity to human recombinant DAAO at 362 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 4.00E+3nMAssay Description:Binding affinity to human recombinant DAAO at 395 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 4.20E+3nMAssay Description:Binding affinity to human recombinant DAAO at 444 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 4.20E+3nMAssay Description:Binding affinity to human recombinant DAAO at 498 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 4.00E+3nMAssay Description:Binding affinity to human recombinant DAAO at 443 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 2.50E+3nMAssay Description:Binding affinity to human recombinant DAAO at 520 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 180nMAssay Description:Binding affinity to human recombinant DAAO at 490 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 130nMAssay Description:Binding affinity to human recombinant DAAO at 490 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 3.70E+3nMAssay Description:Binding affinity to human recombinant DAAO at 492 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 2.20E+3nMAssay Description:Binding affinity to human recombinant DAAO at 492 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 7.00E+3nMAssay Description:Binding affinity to human recombinant DAAO by stopped flow spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 2.30E+3nMAssay Description:Binding affinity to human recombinant DAAO by stopped flow spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 9.00E+3nMAssay Description:Binding affinity to human recombinant DAAO at 442 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 2.60E+4nMAssay Description:Binding affinity to pig kidney DAAO using D-alanine as substrateMore data for this Ligand-Target Pair
Affinity DataKd: 5.00E+3nMAssay Description:Binding affinity to human recombinant DAAO at 520 nm spectral modification by stopped flow spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 6.30E+3nMAssay Description:Binding affinity to human recombinant DAAO by stopped flow spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 1.90E+3nMAssay Description:Binding affinity to human recombinant DAAO by stopped flow spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 5.60E+3nMAssay Description:Binding affinity to human recombinant DAAO at 496 nm spectral modification by spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 700nMAssay Description:Binding affinity to human recombinant DAAO by stopped flow spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair
Affinity DataKd: 6.00E+3nMAssay Description:Binding affinity to human recombinant DAAO by stopped flow spectrophotometric analysis in presence of FADMore data for this Ligand-Target Pair